Cellectis (CLLS) Other Operating Expenses (2015 - 2026)
Cellectis' (CLLS) quarterly Other Operating Expenses came in at $63000.0 in Q1 2026, down 85.21% year-on-year from $426000.0 in Q1 2025, and up 119.69% quarter-over-quarter from -$320000.0 in Q4 2025.
Cellectis (CLLS) Other Operating Expenses (2015 - 2026) Analysis & Trends
Cellectis' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $63000.0 for Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 85.21% year-over-year to $63000.0 in Q1 2026; TTM through Mar 2026 was $275000.0, a 77.82% decrease from a year earlier, with the FY2025 full-year figure at $849000.0, changed 0.0% from the prior year.
- Other Operating Expenses grew to $63000.0 in Q1 2026 per CLLS's latest filing, from -$320000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $839000.0 in Q4 2022 and bottomed at -$1.2 million in Q4 2023.
- The 5-year median for Other Operating Expenses is $63000.0 (2026), against an average of $102294.1.
- Across the five-year window, Other Operating Expenses soared 11885.71% in 2022 and slumped 3009.52% in 2023, its largest moves.
- Year by year, Other Operating Expenses stood at $839000.0 in 2022, then slumped by 243.5% to -$1.2 million in 2023, then surged by 96.1% to -$47000.0 in 2024, then sank by 580.85% to -$320000.0 in 2025, then soared by 119.69% to $63000.0 in 2026.
- Per Business Quant, the three latest CLLS Other Operating Expenses figures stand at $63000.0 (Q1 2026), -$320000.0 (Q4 2025), and $154000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Cellectis | 285.50 Mn | 99.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | -320,000.00 |
| Sep 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 378,000.00 |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Jun 30, 2024 | 686,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | -1.20 Mn |
| Sep 30, 2023 | -12,000.00 |
| Jun 30, 2023 | 528,000.00 |
| Mar 31, 2023 | -611,000.00 |
| Dec 31, 2022 | 839,000.00 |
| Sep 30, 2022 | -125,000.00 |
| Jun 30, 2022 | 753,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 150,000.00 |